Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling

Stimulant drugs are most commonly used to treat ADHD. Here, the authors demonstrate that in adolescents with ADHD who also have genetic variation in genes impacting metabotropic glutamate signaling, the non-stimulant mGluR activator fasoracetam is well tolerated and may be beneficial in alleviating...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Josephine Elia, Grace Ungal, Charlly Kao, Alexander Ambrosini, Nilsa De Jesus-Rosario, Lene Larsen, Rosetta Chiavacci, Tiancheng Wang, Christine Kurian, Kanani Titchen, Brian Sykes, Sharon Hwang, Bhumi Kumar, Jacqueline Potts, Joshua Davis, Jeffrey Malatack, Emma Slattery, Ganesh Moorthy, Athena Zuppa, Andrew Weller, Enda Byrne, Yun R. Li, Walter K. Kraft, Hakon Hakonarson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/f704f752c78842ffbb277c912a01949b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f704f752c78842ffbb277c912a01949b
record_format dspace
spelling oai:doaj.org-article:f704f752c78842ffbb277c912a01949b2021-12-02T17:31:58ZFasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling10.1038/s41467-017-02244-22041-1723https://doaj.org/article/f704f752c78842ffbb277c912a01949b2018-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-02244-2https://doaj.org/toc/2041-1723Stimulant drugs are most commonly used to treat ADHD. Here, the authors demonstrate that in adolescents with ADHD who also have genetic variation in genes impacting metabotropic glutamate signaling, the non-stimulant mGluR activator fasoracetam is well tolerated and may be beneficial in alleviating symptoms of this disease.Josephine EliaGrace UngalCharlly KaoAlexander AmbrosiniNilsa De Jesus-RosarioLene LarsenRosetta ChiavacciTiancheng WangChristine KurianKanani TitchenBrian SykesSharon HwangBhumi KumarJacqueline PottsJoshua DavisJeffrey MalatackEmma SlatteryGanesh MoorthyAthena ZuppaAndrew WellerEnda ByrneYun R. LiWalter K. KraftHakon HakonarsonNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-9 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Josephine Elia
Grace Ungal
Charlly Kao
Alexander Ambrosini
Nilsa De Jesus-Rosario
Lene Larsen
Rosetta Chiavacci
Tiancheng Wang
Christine Kurian
Kanani Titchen
Brian Sykes
Sharon Hwang
Bhumi Kumar
Jacqueline Potts
Joshua Davis
Jeffrey Malatack
Emma Slattery
Ganesh Moorthy
Athena Zuppa
Andrew Weller
Enda Byrne
Yun R. Li
Walter K. Kraft
Hakon Hakonarson
Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
description Stimulant drugs are most commonly used to treat ADHD. Here, the authors demonstrate that in adolescents with ADHD who also have genetic variation in genes impacting metabotropic glutamate signaling, the non-stimulant mGluR activator fasoracetam is well tolerated and may be beneficial in alleviating symptoms of this disease.
format article
author Josephine Elia
Grace Ungal
Charlly Kao
Alexander Ambrosini
Nilsa De Jesus-Rosario
Lene Larsen
Rosetta Chiavacci
Tiancheng Wang
Christine Kurian
Kanani Titchen
Brian Sykes
Sharon Hwang
Bhumi Kumar
Jacqueline Potts
Joshua Davis
Jeffrey Malatack
Emma Slattery
Ganesh Moorthy
Athena Zuppa
Andrew Weller
Enda Byrne
Yun R. Li
Walter K. Kraft
Hakon Hakonarson
author_facet Josephine Elia
Grace Ungal
Charlly Kao
Alexander Ambrosini
Nilsa De Jesus-Rosario
Lene Larsen
Rosetta Chiavacci
Tiancheng Wang
Christine Kurian
Kanani Titchen
Brian Sykes
Sharon Hwang
Bhumi Kumar
Jacqueline Potts
Joshua Davis
Jeffrey Malatack
Emma Slattery
Ganesh Moorthy
Athena Zuppa
Andrew Weller
Enda Byrne
Yun R. Li
Walter K. Kraft
Hakon Hakonarson
author_sort Josephine Elia
title Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
title_short Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
title_full Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
title_fullStr Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
title_full_unstemmed Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
title_sort fasoracetam in adolescents with adhd and glutamatergic gene network variants disrupting mglur neurotransmitter signaling
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/f704f752c78842ffbb277c912a01949b
work_keys_str_mv AT josephineelia fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT graceungal fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT charllykao fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT alexanderambrosini fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT nilsadejesusrosario fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT lenelarsen fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT rosettachiavacci fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT tianchengwang fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT christinekurian fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT kananititchen fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT briansykes fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT sharonhwang fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT bhumikumar fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT jacquelinepotts fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT joshuadavis fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT jeffreymalatack fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT emmaslattery fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT ganeshmoorthy fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT athenazuppa fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT andrewweller fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT endabyrne fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT yunrli fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT walterkkraft fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
AT hakonhakonarson fasoracetaminadolescentswithadhdandglutamatergicgenenetworkvariantsdisruptingmglurneurotransmittersignaling
_version_ 1718380467353288704